LeadIQ logo
Learn more at LeadIQ.com
✕

Access Insights for Sonoma Biotherapeutics and Millions of Other Companies

Sign up for full access to Sonoma Biotherapeutics information. No credit card needed.
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Insights

Strategic Partnerships Sonoma Biotherapeutics has established strategic collaborations with prominent companies like Regeneron and VEOPOZ, indicating potential avenues for joint sales efforts and cross-promotion opportunities.

Funding and Expansion Recent funding rounds totaling $75 million, along with partnerships and investments from key industry players, highlight a strong financial position that can support expansion initiatives and accelerate sales growth.

Top Talent Recruitment The recruitment of experienced executives such as Dr. Joseph R. Arron and Dr. Mark D. Eisner demonstrates a commitment to assembling a high-caliber team, potentially fostering strong sales leadership and market penetration strategies.

Product Development Focus Focused on developing cutting-edge regulatory T cell therapies for autoimmune diseases, Sonoma Biotherapeutics' innovative approach presents opportunities to meet unmet medical needs and drive sales through differentiated product offerings.

Market Differentiation With a unique focus on engineered Treg therapies and a strong pipeline of novel treatments, Sonoma Biotherapeutics stands out in the biotechnology research industry, providing a competitive edge that can be leveraged for sales differentiation and market positioning.

Similar companies to Sonoma Biotherapeutics

✕

Access Insights for Sonoma Biotherapeutics and Millions of Other Companies

Sign up for full access to Sonoma Biotherapeutics information. No credit card needed.
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Sonoma Biotherapeutics Tech Stack

Sonoma Biotherapeutics uses 8 technology products and services including Microsoft Word, Microsoft Excel, Google Workspace, and more. Explore Sonoma Biotherapeutics's tech stack below.

  • Microsoft Word
    Editors
  • Microsoft Excel
    Editors
  • Google Workspace
    Email
  • Open Graph
    Miscellaneous
  • Smartsheet
    Project Management
  • Minitab
    Visualisation Software
  • Zoom
    Web Conferencing
  • Linkedin
    Widgets

Media & News

Sonoma Biotherapeutics's Email Address Formats

Sonoma Biotherapeutics uses at least 1 format(s):
Sonoma Biotherapeutics Email FormatsExamplePercentage
FLast@sonomabio.comJDoe@sonomabio.com
94%
FMiddleLast@sonomabio.comJMichaelDoe@sonomabio.com
3%
First.Last@sonomabio.comJohn.Doe@sonomabio.com
2%
Middle@sonomabio.comMichael@sonomabio.com
1%

Frequently Asked Questions

Where is Sonoma Biotherapeutics's headquarters located?

Minus sign iconPlus sign iconSonoma Biotherapeutics's main headquarters is located at 201 Haskins Way South San Francisco, California 94080 US. The company has employees across 4 continents, including North AmericaAsiaEurope.

What is Sonoma Biotherapeutics's official website and social media links?

Minus sign iconPlus sign iconSonoma Biotherapeutics's official website is sonomabio.com and has social profiles on LinkedIn.

How much revenue does Sonoma Biotherapeutics generate?

Minus sign iconPlus sign icon As of October 2024, Sonoma Biotherapeutics's annual revenue reached $15M.

What is Sonoma Biotherapeutics's SIC code NAICS code?

Minus sign iconPlus sign iconSonoma Biotherapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Sonoma Biotherapeutics have currently?

Minus sign iconPlus sign iconAs of October 2024, Sonoma Biotherapeutics has approximately 129 employees across 4 continents, including North AmericaAsiaEurope. Key team members include Chief Executive Officer: J. S.Chief Financial Officer: J. S.Chief Scientific Officer: J. A.. Explore Sonoma Biotherapeutics's employee directory with LeadIQ.

What industry does Sonoma Biotherapeutics belong to?

Minus sign iconPlus sign iconSonoma Biotherapeutics operates in the Biotechnology Research industry.

What technology does Sonoma Biotherapeutics use?

Minus sign iconPlus sign iconSonoma Biotherapeutics's tech stack includes Microsoft WordMicrosoft ExcelGoogle WorkspaceOpen GraphSmartsheetMinitabZoomLinkedin.

What is Sonoma Biotherapeutics's email format?

Minus sign iconPlus sign iconSonoma Biotherapeutics's email format typically follows the pattern of . Find more Sonoma Biotherapeutics email formats with LeadIQ.

How much funding has Sonoma Biotherapeutics raised to date?

Minus sign iconPlus sign icon As of October 2024, Sonoma Biotherapeutics has raised $30M in funding. The last funding round occurred on Mar 28, 2023 for $30M.
Sonoma Biotherapeutics

Sonoma Biotherapeutics

Biotechnology ResearchCalifornia, United States51-200 Employees

Sonoma Biotherapeutics is developing engineered regulatory T cell (Treg) therapies to treat serious autoimmune and inflammatory diseases driven by an imbalanced immune system. Founded by pioneers in Treg biology and cell therapy, the company is employing proprietary platform technologies and approaches to develop a new generation of targeted Treg cell therapies designed to induce durable immune tolerance to treat and prevent autoimmune and inflammatory diseases. Sonoma Biotherapeutics is based in South San Francisco and Seattle.

✕

Access Insights for Sonoma Biotherapeutics and Millions of Other Companies

Sign up for full access to Sonoma Biotherapeutics information. No credit card needed.
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Section iconCompany Overview

Headquarters
201 Haskins Way South San Francisco, California 94080 US
Website
sonomabio.com
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
51-200

Section iconMedia & News

Section iconFunding & Financials

  • $30M

    Sonoma Biotherapeutics has raised a total of $30M of funding over 4 rounds. Their latest funding round was raised on Mar 28, 2023 in the amount of $30M.

  • $10M$50M

    Sonoma Biotherapeutics's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $30M

    Sonoma Biotherapeutics has raised a total of $30M of funding over 4 rounds. Their latest funding round was raised on Mar 28, 2023 in the amount of $30M.

  • $10M$50M

    Sonoma Biotherapeutics's revenue is in the range of $10M$50M

Company Leadership

Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

✕

Access Insights for Sonoma Biotherapeutics and Millions of Other Companies

Sign up for full access to Sonoma Biotherapeutics information. No credit card needed.
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.